Clinical trial
Single Cell Sequencing Analysis of Thymoma
NCT04162691 is registered in ClinicalTrials.gov with Zhejiang Cancer Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Single Cell Sequencing Analysis of Thymoma
- Lead sponsor
- Zhejiang Cancer Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- June 6, 2020
- Completion date
- December 31, 2023
- Enrollment
- 10 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.